| Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy N Vigneron, M Meryet-Figuière, A Guttin, JP Issartel, B Lambert, M Briand, ... Molecular oncology 10 (7), 981-992, 2016 | 86 | 2016 |
| The lncRNA ‘UCA1’modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels A Wambecke, M Ahmad, PM Morice, B Lambert, LB Weiswald, M Vernon, ... Molecular oncology 15 (12), 3659-3678, 2021 | 24 | 2021 |
| Updates and current challenges in microRNA research for personalized medicine in ovarian cancer V Mandilaras, M Vernon, M Meryet-Figuière, K Karakasis, B Lambert, ... Expert Opinion on Biological Therapy 17 (8), 927-943, 2017 | 21 | 2017 |
| Predictive relevance of circulating miR-622 in patients with newly diagnosed and recurrent high-grade serous ovarian carcinoma N Vigneron, M Vernon, M Meryet-Figuière, B Lambert, M Briand, ... Clinical Chemistry 66 (2), 352-362, 2020 | 19 | 2020 |
| Functional miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and reveals a new therapeutic combination strategy in ovarian tumor organoids M Vernon, B Lambert, M Meryet-Figuière, E Brotin, LB Weiswald, ... Molecular Cancer Therapeutics 19 (7), 1506-1519, 2020 | 17 | 2020 |
| Lysosomal lipid peroxidation regulates tumor immunity M Bhardwaj, JJ Lee, AM Versace, SL Harper, AR Goldman, MAS Crissey, ... The Journal of Clinical Investigation 133 (8), 2023 | 12 | 2023 |
| A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma W Cai, MQ Nguyen, NA Wilski, TJ Purwin, M Vernon, M Tiago, AE Aplin Cancer research 82 (14), 2625-2639, 2022 | 12 | 2022 |
| Raptinal induces gasdermin E–dependent pyroptosis in naïve and therapy-resistant melanoma M Vernon, NA Wilski, D Kotas, W Cai, D Pomante, M Tiago, ES Alnemri, ... Molecular Cancer Research 20 (12), 1811-1821, 2022 | 10 | 2022 |
| Network-based integration of multi-omics data identifies the determinants of miR-491-5p effects M Meryet-Figuiere, M Vernon, M Andrianteranagna, B Lambert, ... Cancers 13 (16), 3970, 2021 | 2 | 2021 |
| Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors E Dolivet, L Gaichies, C Jeanne, C Bazille, M Briand, M Vernon, F Giffard, ... International Journal of Molecular Sciences 24 (21), 16016, 2023 | | 2023 |
| A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors W Cai, NA Wilski, TJ Purwin, M Vernon, M Tiago, AE Aplin | | 2022 |
| PREDICTIVE AND PROGNOSTIC USE OF A miRNA FOR HIGH GRADE SEROUS OVARIAN CARCINOMA THERAPEUTIC CARE N Vigneron, C Denoyelle, L Poulain, JP Issartel, B Lambert, ... US Patent App. 17/253,363, 2021 | | 2021 |
| Caractérisation des cibles de microARNs tueurs et des réseaux de régulation associés dans les cancers de l'ovaire M Vernon Normandie, 2018 | | 2018 |
